Table 3 The 5-year relative survival of lung cancer in different time periods
Characteristic | Case | 2011–2014 | 2015–2017 | 2018–2020 | Average change(95%CI) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
5-year RS(%) | 95%CI | 5-year RS(%) | 95%CI | 5-year RS(%) | 95%CI | |||||
Total | 22,153 | 13.8 | 12.9–14.7 | 18.2 | 17.2–19.3 | 23.7 | 22.4–24.9 | 4.9%(0.8-9.0) | ||
Sex | ||||||||||
Male | 8336 | 11.9 | 11.0-12.9 | 14.5 | 13.4–15.7 | 17.2 | 15.9–18.5 | 2.6%(2.3-3.0) | ||
Female | 4660 | 18.4 | 16.6–20.4 | 26.3 | 24.3–28.5 | 36.0 | 33.4–38.6 | 8.7%(1.9–15.5) | ||
Age group | ||||||||||
<45 | 1129 | 19.9 | 15.4–24.9 | 40.1 | 33.9–46.2 | 48.4 | 41.1–55.4 | 15.0%(-26.9-56.9) | ||
45–54 | 3110 | 15.5 | 13.1–18.1 | 27.7 | 24.6–30.8 | 38.6 | 34.7–42.5 | 11.6%(6.9–16.4) | ||
55–64 | 6280 | 15.7 | 14.1–17.4 | 23.0 | 21.0-25.1 | 29.0 | 26.7–31.4 | 6.7%(1.9–11.5) | ||
65–74 | 6489 | 13.2 | 11.7–14.9 | 14.8 | 13.1–16.7 | 19.4 | 17.4–21.5 | 2.9%(-7.9-13.9) | ||
≥ 75 | 5145 | 9.8 | 8.2–11.6 | 7.9 | 6.4–9.7 | 7.9 | 6.1–10.1 | -1.0%(-8.3-6.3) | ||
Histology Type | ||||||||||
Adenocarcinoma | 9158 | 20.6 | 18.6–22.4 | 33.4 | 31.3–35.4 | 47.1 | 44.6–49.6 | 13.2%(9.7–16.7) | ||
Squamous cell carcinoma | 2383 | 16.3 | 13.6–19.3 | 15.7 | 13.0-18.6 | 18.3 | 15.3–21.5 | 0.9%(-11.2-13.1) | ||
Small cell carcinoma | 927 | 7.0 | 4.2–10.8 | 5.4 | 3.0-8.8 | 6.9 | 4.2–10.5 | 0.1%(-10.8-11.1) | ||
Other | 528 | 18.7 | 12.1–26.5 | 23.0 | 16.3–30.5 | 21.4 | 15.3–28.3 | 1.3%(-19.9-23.4) | ||